NO20044575L - Oljelegeme assosierte proteinsammensetninger og fremgangsmater for anvendelse derav for redusering av risikoen for kardiovaskulaer sykdom - Google Patents

Oljelegeme assosierte proteinsammensetninger og fremgangsmater for anvendelse derav for redusering av risikoen for kardiovaskulaer sykdom

Info

Publication number
NO20044575L
NO20044575L NO20044575A NO20044575A NO20044575L NO 20044575 L NO20044575 L NO 20044575L NO 20044575 A NO20044575 A NO 20044575A NO 20044575 A NO20044575 A NO 20044575A NO 20044575 L NO20044575 L NO 20044575L
Authority
NO
Norway
Prior art keywords
methods
risk
cardiovascular disease
oil body
reduce
Prior art date
Application number
NO20044575A
Other languages
English (en)
Other versions
NO333937B1 (no
Inventor
Neal A Bringe
Kanthasamy Karunanandaa
Original Assignee
Monsanto Technology Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Technology Llc filed Critical Monsanto Technology Llc
Publication of NO20044575L publication Critical patent/NO20044575L/no
Publication of NO333937B1 publication Critical patent/NO333937B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/14—Vegetable proteins
    • A23J3/16—Vegetable proteins from soybean
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
    • A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
    • A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
    • A23J3/347—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of proteins from microorganisms or unicellular algae
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/185—Vegetable proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)

Abstract

Preparater og metoder for reduksjon av hyperkolesterolemi og følgelig, risiko for kardiovaskulær sykdom, er tilveiebragt. Slike preparater kan omfatte isolerte oljelegeme- assosierte proteiner. I tillegg tilveiebringes matvarer til hvilke ett eller flere oljelegemeassosierte proteiner er tilsatt. Preparatene anvendt i oppfinnelsen kan videre omfatte additivforbindelser, for eksempel et saponin, et isoflavon, et fosfolipid, et karbohydrat i det vesentlige resistent mot fordøyelse eller en kombinasjon derav. Metodene og preparatene ifølge foreliggende oppfinnelse kan anvendes for å senke kolesterol- og andre lipid-nivåer hos individer for å oppnå en reduksjon av risiko for kardiovaskulær sykdom.
NO20044575A 2002-04-18 2004-10-25 Metode for fremstilling av et næringsmiddel, sammensetning og næringsmiddel for behandling eller forebygging av hyperkolesterolemi, samt anvendelse derav. NO333937B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37346002P 2002-04-18 2002-04-18
PCT/US2003/012009 WO2003088749A1 (en) 2002-04-18 2003-04-17 Oil body associated protein compositions and methods of use thereof for reducing the risk of cardiovascular disease

Publications (2)

Publication Number Publication Date
NO20044575L true NO20044575L (no) 2005-01-17
NO333937B1 NO333937B1 (no) 2013-10-28

Family

ID=29251031

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044575A NO333937B1 (no) 2002-04-18 2004-10-25 Metode for fremstilling av et næringsmiddel, sammensetning og næringsmiddel for behandling eller forebygging av hyperkolesterolemi, samt anvendelse derav.

Country Status (13)

Country Link
US (1) US7541329B2 (no)
EP (1) EP1494536B1 (no)
JP (1) JP5219326B2 (no)
KR (1) KR101238752B1 (no)
CN (2) CN1662142A (no)
AU (1) AU2003221982B2 (no)
BR (1) BRPI0309421B8 (no)
CA (1) CA2482464C (no)
IL (1) IL164647A (no)
MX (1) MXPA04010310A (no)
NO (1) NO333937B1 (no)
NZ (1) NZ536466A (no)
WO (1) WO2003088749A1 (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20020147A1 (it) * 2002-01-29 2003-07-29 Indena Spa Estrazione purificazione e modificazione di polipeptidi da seme di soia
EP1799831A4 (en) * 2004-10-06 2007-11-21 Sembiosys Genetics Inc PROCESS FOR MODULATING OLEOSINE EXPRESSION IN PLANTS
JPWO2006101181A1 (ja) * 2005-03-23 2008-09-04 不二製油株式会社 肝機能障害予防もしくは改善組成物、及び肝機能障害予防もしくは改善法
WO2007026674A1 (ja) * 2005-08-29 2007-03-08 Fuji Oil Company, Limited 大豆蛋白質組成物を配合する麺類および麺皮類
US7695744B1 (en) 2005-11-16 2010-04-13 Kareem M Zubair Natural supplement of cholesterol lowering oil seeds and nuts and method of manufacture
JP4963044B2 (ja) * 2006-07-05 2012-06-27 不二製油株式会社 ユビキチンリガーゼ阻害剤
JP3944864B1 (ja) * 2006-07-31 2007-07-18 株式会社Ｊ−オイルミルズ メタボリックシンドロームの予防および改善用組成物
US9101161B2 (en) * 2006-11-02 2015-08-11 The Coca-Cola Company High-potency sweetener composition with phytoestrogen and compositions sweetened therewith
US8124157B2 (en) * 2006-12-14 2012-02-28 Fuji Oil Company, Limited Noodles and noodle skins comprising soybean protein composition and the method of making same
WO2009089115A1 (en) * 2008-01-04 2009-07-16 Hormel Foods Corporation Encapsulation of oxidatively unstable compounds
US20110020519A1 (en) * 2008-01-04 2011-01-27 Aveka, Inc. Encapsulation of oxidatively unstable compounds
JP5752874B2 (ja) * 2008-08-08 2015-07-22 株式会社ファンケル 血流改善組成物
US20120070520A1 (en) * 2009-05-26 2012-03-22 Hyun Jung Shin Composition containing a bean extract for improving blood circulation and increasing vascular health
EP2611283B1 (en) 2010-08-30 2016-08-10 Ben-Gurion University Of The Negev Research And Development Authority Oil globule protein and uses thereof
WO2012097220A2 (en) * 2011-01-13 2012-07-19 The Trustees Of The University Of Pennsylvania Novel vesicles and nanostructures from recombinant proteins
US20140024714A1 (en) * 2011-02-07 2014-01-23 Commonwealth Scientific And Industrial Research Organisation Artificial oil bodies
WO2013052853A2 (en) * 2011-10-07 2013-04-11 Purdue Research Foundation Products containing partially hydrolyzed soy beta-conglycinin, and related methods
CN118206611A (zh) * 2022-12-15 2024-06-18 中国科学院大连化学物理研究所 一种细胞表面蛋白靶向化合物及细胞表面蛋白富集方法

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3642490A (en) 1967-03-27 1972-02-15 Ralston Purina Co Method of treating vegetable protein
US3694221A (en) 1970-01-30 1972-09-26 Ralston Purina Co Enzyme modified protein process
US4360537A (en) 1976-05-03 1982-11-23 International Telephone And Telegraph Corporation Lipoprotein emulsions for food use and methods for preparing the same
NZ183822A (en) * 1976-05-03 1980-05-08 Itt Method for preparing a lipoprotein emulsion :an egg yolk replacer
US5725899A (en) * 1978-03-16 1998-03-10 Cole; Morton S. Protein-lipid emulsifying and gelling composition and method of preparing same
CN86105538A (zh) 1986-07-25 1988-02-24 平乡县粮食局油脂加工厂 一种食用油精炼方法
WO1989001495A1 (fr) 1987-08-07 1989-02-23 Fuji Oil Company, Limited Agent abaisseur du niveau de cholesterol
JPH0725796B2 (ja) * 1987-08-07 1995-03-22 不二製油株式会社 降コレステロール物質
CA2077020A1 (en) 1991-09-03 1993-03-04 Yoshikazu Isono Process for producing lipoprotein-containing substance having reduced lipid content and food containing substance thus produced
FR2681219B1 (fr) 1991-09-16 1993-11-26 Ard Sa Produit lipidoproteique derive de la farine de ble, son procede de preparation et ses applications.
JPH05168428A (ja) * 1991-12-21 1993-07-02 Yuichiro Onozuka 大豆からの麺状食品製造法
EP0656786B2 (en) * 1992-05-19 2014-04-23 Novogen Research Pty Ltd Use of isoflavone phyto-oestrogen extracts of soy or clover
US5559220A (en) * 1993-09-14 1996-09-24 Midwest Research Institute Gene encoding acetyl-coenzyme A carboxylase
EP0790060B1 (en) * 1995-09-06 2003-11-12 Kyowa Hakko Kogyo Co., Ltd. Substance ameliorant le metabolisme des graisses
US5968516A (en) * 1995-10-03 1999-10-19 Liu; Yaguang Soybean drug and new method of extracting soybean saponins
PL184852B1 (pl) 1996-02-29 2002-12-31 Nutri Pharma As Kompozycja na bazie składników soi
US6171640B1 (en) * 1997-04-04 2001-01-09 Monsanto Company High beta-conglycinin products and their use
US5855892A (en) 1997-09-19 1999-01-05 Potter; Susan M. Method for decreasing LDL-cholesterol concentration and increasing HDL-cholesterol concentration in the blood to reduce the risk of atherosclerosis and vascular disease
IL137153A (en) * 1998-01-07 2003-07-31 Diamond George B Crisp fried in grapeseed oil
AU3085299A (en) * 1998-03-12 1999-09-27 Board Of Trustees Of The University Of Arkansas, The Tertiary structure of peanut allergen ara h 1
JP3030339B2 (ja) * 1998-08-07 2000-04-10 農林水産省農業生物資源研究所長 ダイズグリシニンを発現するトランスジェニック植物
MXPA01005276A (es) 1998-11-25 2002-04-24 Sembiosys Genetics Inc Cuerpos grasos como vehiculos de suministro topico para agentes activos.
WO2000030663A1 (en) 1998-11-25 2000-06-02 Nutri Pharma Asa Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of type 2 diabetes, the metabolic syndrome and associated cardiovascular diseases
US6544566B1 (en) * 1999-04-23 2003-04-08 Protein Technologies International, Inc. Composition containing plant sterol, soy protein and isoflavone for reducing LDL cholesterol
US6413569B1 (en) * 1999-09-29 2002-07-02 Archer-Daniels-Midland Company Use of isolated soy protein for making fresh, unripened cheese analogs
JP3441411B2 (ja) 1999-10-12 2003-09-02 明治乳業株式会社 コレステロール低減化ペプチド
ATE270340T1 (de) 1999-11-18 2004-07-15 Nestle Sa Rekombinante oleosine aus kakao und deren verwendung als geschmacksstoffe oder emulgatoren
US6864362B2 (en) * 2000-03-16 2005-03-08 E. I. Du Pont De Nemours And Company Hypoallergenic transgenic soybeans
JP3619137B2 (ja) 2000-09-28 2005-02-09 日本水産株式会社 オイルボディ様またはシェル状ナノカプセルおよびその製造方法
AU2001290293A1 (en) * 2000-09-28 2002-04-08 Ajinomoto Co. Inc. Oleosin/phospholipid complex and process for producing the same
AU2001290324A1 (en) * 2000-09-29 2002-04-08 Fuji Oil Company Limited Composition for diminishing neutral fat in blood
CN1237890C (zh) * 2000-10-02 2006-01-25 不二制油株式会社 分级大豆蛋白及其生产方法

Also Published As

Publication number Publication date
KR101238752B1 (ko) 2013-03-06
KR20050060031A (ko) 2005-06-21
IL164647A0 (en) 2005-12-18
NO333937B1 (no) 2013-10-28
JP5219326B2 (ja) 2013-06-26
EP1494536A1 (en) 2005-01-12
US20050214346A1 (en) 2005-09-29
CN102240040B (zh) 2014-12-24
MXPA04010310A (es) 2005-02-17
BRPI0309421B8 (pt) 2021-05-25
BR0309421A (pt) 2005-02-01
EP1494536A4 (en) 2009-10-28
HK1162127A1 (en) 2012-08-24
BRPI0309421B1 (pt) 2018-06-26
AU2003221982A1 (en) 2003-11-03
BRPI0309421A8 (pt) 2017-12-05
NZ536466A (en) 2008-04-30
IL164647A (en) 2009-07-20
JP2005523007A (ja) 2005-08-04
WO2003088749A1 (en) 2003-10-30
CA2482464C (en) 2013-06-25
CA2482464A1 (en) 2003-10-30
CN102240040A (zh) 2011-11-16
AU2003221982B2 (en) 2009-04-23
EP1494536B1 (en) 2013-06-19
US7541329B2 (en) 2009-06-02
CN1662142A (zh) 2005-08-31

Similar Documents

Publication Publication Date Title
NO20044575L (no) Oljelegeme assosierte proteinsammensetninger og fremgangsmater for anvendelse derav for redusering av risikoen for kardiovaskulaer sykdom
Bernstein et al. 2 Inhibitors of human leukocyte elastase
Angeles et al. Legumes as functional food for cardiovascular disease
Kamal et al. Amaranth proteins as potential source of bioactive peptides with enhanced inhibition of enzymatic markers linked with hypertension and diabetes
Dewell et al. A critical evaluation of the role of soy protein and isoflavone supplementation in the control of plasma cholesterol concentrations
Zhu et al. Edible dry bean consumption (Phaseolus vulgaris L.) modulates cardiovascular risk factors and diet-induced obesity in rats and mice
PL368976A1 (en) Composition for lowering blood cholesterol
DE60113381D1 (de) Automatisierung im proteinentwurf durch proteinbibliotheken
WO2002015719A3 (en) Nutritional composition
BRPI0412444B8 (pt) fração de quil a com baixa toxidez e seu uso
WO2003075858A3 (en) Bicyclic heterocycles for the treatment of diabetes and other diseases
WO2002069886A3 (en) Modified proteins, designer toxins, and methods of making thereof
BR0001672A (pt) Composição e método para redução da cocentração de colesterol lipoprotéico de baixa densidade
NO20035301D0 (no) Små molekyl¶re antagonister av proteiner i BCL-2-familien
EP2147680A3 (en) Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
WO2003014325A3 (en) Protein design automation for protein libraries
BR9712731A (pt) Fitase a partir de feijões de soja germinados
ATE264093T1 (de) Sojazubereitungen und deren verwendung zur gesundheitsförderung
Frota et al. Cowpea protein reduces LDL-cholesterol and apolipoprotein B concentrations, but does not improve biomarkers of inflammation or endothelial dysfunction in adults with moderate hypercholesterolemia
DE60025008D1 (de) Bestimmung von adrenomedullin-bindenden proteinen
NZ233784A (en) Pharmaceutical composition comprising an inclusion compound of imipramine or derivative in cyclodextrin
MXPA02011476A (es) Fuente de triptofano de plantas y usos para el mismo.
NO20085147L (no) Sammensetning for behandling av motstandsdyktige kreftformer omfattende oridonin
Barnes et al. IgE-reactive proteins from Stachybotrys chartarum
DE69229269D1 (de) Peptidfragmente des menschlichen cytochrome p450 iid6, antikörper dagegen und ihre verwendungen in diagnostik

Legal Events

Date Code Title Description
MK1K Patent expired